Shares of C3.ai, Inc. (NYSE:AI) rose sharply in today's pre-market trading session after the company reported better-than-expected second-quarter financial results.

C3.ai reported quarterly losses of six cents per share, which beat the analyst consensus estimate for losses of 16 cents. Quarterly revenue clocked in at $94.34 million, which beat the consensus estimate of $91.02 million and is an increase over sales of $73.23 million from the same period last year.

C3.ai shares jumped 7.8% to $44.91 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Chimerix, Inc. (NASDAQ:CMRX) gained 117.3% to $1.88 in pre-market trading after the company announced it will submit dordaviprone for accelerated approval to the FDA for patients with recurrent H3 K27M-mutant diffuse glioma.
• Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) rose 103.2% to $2.52 in pre-market trading after the company announced the FDA has approved its supplemental new drug application for acetadote.
• TNL Mediagene  (NASDAQ:TNMG) gained 69.8% to $25.81 in pre-market trading.
• Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) gained 54.8% to $1.92 in pre-market trading after jumping around 17% on Monday.
• Gelteq Limited (NASDAQ:GELS) rose 39.8% to $4.98 in pre-market trading after jumping 78% on Monday.
• The Glimpse Group, Inc. (NASDAQ:VRAR) gained 36.9% to $1.15 in pre-market trading after rising over 13% on Monday.
• Nanobiotix S.A. (NASDAQ:NBTX) climbed 21% to $3.63 in pre-market trading. NANOBIOTIX announced the completion of Phase 1 study of NBTXR3 (JNJ-1900) in pancreatic cancer.
• Jet.AI Inc. (NASDAQ:JTAI) gained 20.7% to $5.13 in pre-market trading after jumping 6% on Monday.
• New Era Helium Inc (NASDAQ:NEHC) gained 17.3% to $9.85 in pre-market trading after dipping 29% on Monday.

Losers

Now Read This:

• S&P 500, Nasdaq Retreat From Record Highs As Nvidia Declines Over Chinese Antitrust Concerns: Fear & Greed Index Remains In ‘Neutral’ Zone